Search for: "FOREST PHARMACEUTICALS, INC.," Results 41 - 60 of 177
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Nov 2016, 10:22 am by Overhauser Law Offices, LLC
Defendant Akorn, Inc., a generic drugmaker based in Lake Forest, Illinois, filed an Abbreviated New Drug Application (“ANDA”) with the U.S. [read post]
18 Aug 2014, 12:00 pm by Tom Lamb
  It is from Forest Pharmaceuticals, Inc., who has advertisements for this relatively new drug on television and in magazines. [read post]
29 Jan 2015, 1:34 pm
   Plaintiff, who opted out of the global Lexapro settlement, alleged that defendants, Forest Laboratories, Inc. and Forest Pharmaceuticals, Inc. [read post]
16 Apr 2009, 7:27 am
" Notably, "Eli Lilly and Co., Pfizer Inc., Novartis Pharmaceuticals Corp., Merck & Co. and Forest Pharmaceuticals Inc. were the biggest spenders. [read post]
1 Jul 2010, 1:32 pm by Richard Renner
Grassley letters are available in the continuation of this blog entryBelow are links to the letters sent by Grassley to: Abbott Laboratories Amgen AstraZeneca Pharmaceuticals Boehringer Bristol-Myers Squibb Company Eisai Corporation of America Eli Lilly and Company Forest Laboratories GlaxoSmithKline Hoffman-La Roche Inc. [read post]
6 Apr 2009, 8:20 am
" Among those companies ordered "to stop using the ads" were "Merck & Co., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
15 Jan 2014, 5:43 am by Robert Kreisman
Herndon of the Southern District of Illinois has ordered that Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
31 Jan 2013, 7:30 am by Gene Quinn & Angel Krippner
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
1 Mar 2013, 6:28 am by Gene Quinn
(Nasdaq: MYL) announced that it, along with Famy Care Ltd., has entered into a settlement agreement with Janssen Pharmaceuticals Inc. that will resolve patent litigation related to Ortho Tri-Cyclen Lo® Tablets, which are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. [read post]
9 Jun 2014, 4:51 am by Robert Kreisman
Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. was the direct manufacturer maker of the Risperdal drug. [read post]
18 Mar 2011, 1:12 pm by Eric Schweibenz
According to the Notice of Investigation, the ITC has identified Jiangsu Hansoh Pharmaceutical Co., Ltd. of China, Intas Pharmaceuticals Ltd. of India, ChemWerth, Inc. of Woodbridge, Connecticut, and Hospira, Inc. of Lake Forest, Illinois as the respondents in this investigation. [read post]
23 Apr 2012, 2:21 pm
Hospira is the world’s largest producer of generic injectable pharmaceuticals – such as the recalled product in this case – and is headquartered in Lake Forest, Illinois. [read post]
11 May 2011, 4:20 pm by Juliana Olsson
They’ve already announced plans to do exactly this to Howard Solomon, the CEO of Forest Laboratories, Inc. [read post]